The Present Situation and Thinking of the Whole Course Management of Esophageal Cancer Surgery in the Era of Precision Medicine in the China
Department of Thoracic Surgery, The First People's Hospital of Lianyungang, Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222002, China
| Abstract: | In the 21st century, clinical medicine has entered the era of precision medicine. Under the guidance of the concept and technology of “Precision Medicine, the multidisciplinary diagnostic and Therapeutic Team (MDT) is dominant by the surgery department of esophageal cancer has implemented the standardized, minimally invasive, Precision of radical operation for esophageal cancer and individualized multidisciplinary comprehensive treatment, the resection rate and survival rate were improved. However, in view of the low rate of early diagnosis of esophageal cancer, the diagnosis and treatment are mostly in the middle and late stages, especially the lack of follow-up and management after treatment, which greatly affects the long-term survival rate and quality of life of patients. The whole management of esophageal cancer covers and runs through the screening and early diagnosis of patients before hospital; Accurate diagnosis and treatment and rapid rehabilitation in the hospital; To long-term follow-up monitoring, Subsequent recuperation and health maintenance after discharge in the three stages, To provide patients with all-round, full-cycle and continuous medical care services, rehabilitation guidance and humanistic care, in order to prolong the survival period of patients, improve the life index and the overall curative effect of esophageal cancer. Therefore, it is the development trend of esophageal cancer surgery to construct a new model and management system of integrated and precision whole-course health management. This article summarized the current status of whole course health management of esophageal cancer in the china. |
| Keywords: | Esophageal Cancer; Screening; Precision Diagnosis and Treatment; Whole Process Management |
| DOI: | 10.57237/j.wjcm.2024.03.001 |
View:
Downloads:
Received: 19 July 2024
Accepted: 21 August 2024
Published Online: 29 August 2024
References
| [1] | 中华人民共和国国家卫生健康委员会医政医管局. 食管癌诊疗指南 (2022年版) [J], 中华消化外科杂志, 2022, 21(10): 1247-1268. https://doi.org/10.3760/cma.j.cn115610-20220726-00433 |
| [2] | 赫捷, 陈万青, 李兆申, 等. 中国食管癌筛查与早诊早治指南 (2022, 北京) [J], 中华消化外科杂志, 2022, 21(6): 677-709. https://doi.org/10.3760/cma.j.cn115610-20220517-00282. |
| [3] | 王国清, 魏文强, 乔友林. 食管癌筛查和早诊早治的实践与经验 [J], 中国肿瘤, 2010, 10(1): 4-8. https://doi.org/CNKI:SUN:ZHLU.0.2010-01-005 |
| [4] | Chen R, Zheng R, Zhang S, et al. Patterns and trends in esophageal cancer incidence and mortality in China; an analysis based on Cancer registry data [J], Journal of the National cancer center, 2023, 3(1): 21-27. https://doi.org/10.1016/j.jncc. 2023.01.002. |
| [5] | 毛友生, 高树庚, 王群, 等．中国食管癌临床流行特征及外科治疗概况大数据分析 [J], 中华肿瘤杂志, 2020, 42(3): 228-233. https://doi.org/10.3760/cma.j.cn112152-20191112-00729. |
| [6] | 郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析 [J], 中华肿瘤杂志, 2024, 46(3): 221-231. https://doi.org/10.3760/cma.j.cn.112152-20240119-00035. |
| [7] | 徐志坚, 赵玉达, 陈万青, 等. 基于内镜的体检人群食管癌机会性筛查规范路径专家共识 [J], 中国肿瘤, 2023, 32(9): 643-228. https://doi.org/10.11735/j.issn.1004-0242.2023.09.A001. |
| [8] | 李向柯, 樊青霞. 从国内外临床试验看食管癌的全程管理 [J], 转化医学电子杂志, 2017, 4(5): 61-64. https://doi.org/10.3969/j.issn.2095-6894.2017.05.016. |
| [9] | 李国仁, 戴建华. 我国早期食管癌筛查的研究进展 [J], 中华胸心血管外科杂志, 2021, 37(1): 52-58. https://doi.org/10.3760/cma.j.cn112434-20191114-00407. |
| [10] | 国家消化系统疾病临床医学研究中心(上海), 中华医学会消化内镜学分会, 等. 中国食管鳞癌癌前状态及癌前病变诊断策略专家共识[J], 中华消化内镜杂志, 2020, 37(12): 853-867. https://doi.org/10.3760/cma.j.cn321463-20200928-00807. |
| [11] | He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in china [J]. Chin J Cancer Res, 2020, 32(6): 673-682. https://doi.org/10.21147/j.issn.1000-9604.2020.06.01 |
| [12] | 中华医学会肿瘤学分会早诊早治学组,. 中国食管癌早诊早治专家共识 [J], 中华肿瘤杂志, 2022, 44(10): 1066-1075. https://doi.org/10.3760/ cma.j.cn112152-20220517-00348. |
| [13] | 李国仁, 戴建华. 我国食管癌治疗理念与模式的沿革和进展[J], 中华胸部外科电子杂志, 2023, 10(2): 117-125. https://doi.org/10.3877/cma.j.issn.2095-8773.2023.02.09 |
| [14] | 李浩淼, 孙海波, 郑燕, 等. AJCC／UICC第八版食管及食管胃交界部癌TNM分期解读及中文版主要内容[J]. 中国胸心血管外科临床杂志, 2017, 24(2): 87-92. https://doi.org/10.7507/1007-4848.201612067 |
| [15] | 国家癌症中心, 中国医师协会胸外科医师分会, 中华医学会胸心血管外科学分会, 等. 中国可切除食管癌围手术期诊疗实践指南(2023版) [J], 中华医学杂志, 2023, 103(33): 2552-2570. https://doi.org/10.3760/cma.j.cn112137-20230604-00933 |
| [16] | 殷章居, 李国仁. 食管癌外科的风险因素、评估及对策的思考 [J], 中国胸心血管外科临床杂志 2016, 23(9): 851-858. https://doi.org/10.7507/1007-4848.20160205 |
| [17] | 锁瑞洋, 王芝馀, 陶润仪, 等. 保留食管的食管癌综合治疗的胸外科视角 [J], 中国胸心血管外科临床杂志 2022, 29 (2): 245-250. https://doi.org/10.7507/1007-4848.202103002 |
| [18] | 毛友生, 高树庚, 李印, 等. 中国食管癌研究热点和展望 [J]. 中华胃肠外科杂志, 2023, 26(4): 307-311. https://doi.org/10.3760/cma.j.cn441530-20221222-00535. |
| [19] | 宗正东, 姜凯元, 田东. 局部晚期食管癌综合治疗研究进展 [J], 肿瘤预防与治疗, 2022, 35(4): 393-398. https://doi.org/10.3969/j.issn.1674-0904.2022.04.014 |
| [20] | 于振涛, 弓磊, 杨月阳, 等. 食管癌外科综合治疗进展 [J], 中华消化外科杂志, 2022, 21(1): 30-33. https://doi.org/10.3760/cma.j.cn115610-20211230-00690 |
| [21] | Shah M A, Altorki N, Patel P, et al. Improving outcomes in patients with Esophageal cancer [J], Nature Reviews Clinical oncology, 2023, 20 (6): 390-407. https://doi.org/10.1038/s41571.023.00757.y |
| [22] | 谭黎杰, 林栋. 食管癌新辅助治疗时代关于病理反应预测与食管保留策略的思考 [J], 中华消化外科杂志, 2019, 18(6): 528-531. https://doi.org/10.3760/cma.j.cn1673-9252.2019. 06. 004. |
| [23] | 中国抗癌协会肿瘤放放射治疗专业委员会, 中华医学会放射肿瘤治疗学分会, 等. 食管癌放疗联合免疫治疗专家共识 (2023年版) [J], 中华放射医学与防护杂志, 2023, 43(8): 575-587. https://doi.org/10.3760/cma.j.cn.112271-00230626-00207 |
| [24] | 中国中西医结合学会. 中西医结合食管癌治疗方案专家共识(2021年版) [J], 中日友好医院学报, 2021, 35(1): 3-7. https://doi.org/10.3969/j.issn.1001.0025.2021.01.001 |
| [25] | 郭旭峰, 姜皓耀, 华荣, 等．2015年上海市胸科医院食管癌外科治疗数据报告 [J], 中国胸心血管外科临床杂志, 2020, 27(9): 1070-1074. https://doi.org/10.7507/1007-4848.202008007. |
| [26] | 李志刚, 张晓彬, 郭旭峰, 等．外科治疗食管鳞癌的长期生存结果—上海市胸科医院单中心结果分析 [J], 中华胸部外科电子杂志, 2018, 5(2): 69-74. https://doi.org/CNKI:SUN:XBWK.0.2018-02-001 |
| [27] | 吴汉然, 柳常青, 解明然. 充气式纵膈镜食管癌切除术中国专家共识 [J], 中国胸心血管外科临床杂志, 2023, 30(10): 1367-1376. https://doi.org/10.7507/1007-4848.202308007. |
| [28] | 王国俊. 膜解剖理念在食管癌根治术中的应用 [J], 中华胃肠外科杂志, 2023, 26(7): 644-649. https://doi.org/10.3760/cma.j.cn.441530-2003.045. |
| [29] | 王云, 吴泽昊, 黄宇光, 等. 《食管切除术围术期治疗指南: 加速康复外科协会推荐》解读, 协和医学杂志, 2019, 10(6): 575-581. https://doi.org/CNKI:SUN:XHYX.0.2019-06-006 |
| [30] | 李印, 孙海波. 食管癌加速康复外科治疗策略与展望 [J], 中华胃肠外科杂志, 2016, 19(09): 965-970. https://doi.org/10.3877/cma.j.issn.2095-8773.2017.03.03 |
| [31] | 中国抗癌协会肿瘤营养专业委员会, 中华医学会肠外肠内营养学分会, 等. 食管癌患者营养治疗指南 [J], 肿瘤代谢与营养电子杂志, 2020, 7(1): 32-42. https://doi.org/10.16689/j.cnki.cn.11-9349/r.2020.01.007. |
| [32] | 倪云峰, 姜涛. 食管癌术后远期生命质量影响因素的研究进展 [J], 中华消化外科杂志, 2022, 21(10): 1342-1346. https://doi.org/10.3760/cma.j.cn115610-20220831-00483 |
| [33] | 马飞, 黎立喜. 肿瘤全方位全周期健康管理 [J], 中华医学杂志, 2024, 104(2): 100-106. https://doi.org/10.3760/cma.j.cn112137-20230818-00256 |
| [34] | 陈龙奇, 李小飞, 傅建华, 等. 食管鳞癌术后随访中国胸外科专家共识 [J], 中国胸心血管外科临床杂志, 2022, 29(2): 141-149. https://doi.org/10.75071007-4848.202112054. |
| [35] | 邓婷, 巴一. 肿瘤患者支持治疗的进展 [J], 中国肿瘤临床, 2022, 49(9): 433-437. https://doi.org/10.12354/j.jssn.11000-8179.2022.20211712. |
Join the Editorial Board
We invite active, qualified and high profile scientists and researchers to join as Editorial Board Members.
Join UsBecome a Reviewer
Scholars with a strong interest in reviewing are invited to join the reviewer panel to ensure the quality of the research to be published.
Join Us